Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wieslaw Gessner is active.

Publication


Featured researches published by Wieslaw Gessner.


FEBS Letters | 1985

Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B

Richard R. Fritz; Creed W. Abell; Nutan T. Patel; Wieslaw Gessner; Arnold Brossi

The neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) was oxidized to dihydropyridine MPDP+ and pyridine MPP+ by preparations of monoamine oxidase B (MAO B), including pure human liver MAO B:monoclonal antibody complex. K m,app values for MPTP and benzylamine, a preferred MAO B substrate, were 316 and 64 μM, respectively. 4‐Phenyl‐1,2,3,6‐tetrahydropyridine (PTP), the nor derivative of MPTP, was also a substrate (K m,app = 221μM). MPDP+ MPTP, and MPP+, but not PTP, were found tobe irreversible inhibitors of MAO B. Our studies support the hypothesis that MPTP is oxidized in primate brain by MAO B to MPDP+ which is then converted to MPP+ a major metabolite found in the substantia nigra.


FEBS Letters | 1985

Serotonergic conversion of MPTP and dopaminergic accumulation of MPP

Rong-Sen Shen; Creed W. Abell; Wieslaw Gessner; Arnold Brossi

[3H]MPP+ had lower K m and higher V max values for its accumulation in rat brain synaptosomes than did [3H]MPTP. The kinetic parameters favored the uptake of [3H]MPP+ in the striatum to that in hypothalamus, whereas they were equally favorable for the uptake of [3H]MPTP in both regions. Hypothalamic uptake of [3H]MPTP and [3H]MPP+ was inhibited by desipramine, imipramine, norepinephrine, and serotonin. Striatal uptake of [3H]MPP+ and [3H]MPTP was blocked by nomifensine and dopamine. These results support the concept that MPTP accumulates in serotonergic neurons where it is oxidized by monoamine oxidase B to MPP+, which is released and then is selectively accumulated in dopaminergic neurons via the dopamine uptake system.


Neuroscience Letters | 1987

MPTP metabolites inhibit rat brain glutathione S-transferases

Yogesh C. Awasthi; Shivendra V. Singh; Rong-Sen Shen; Creed W. Abell; Wieslaw Gessner; Arnold Brossi

1-Methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenyl-pyridinium species, metabolites of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, non-competitively inhibit glutathione S-transferases of rat brain in vitro. The Ki values for 1-methyl-4-phenyl-2,3-dihydropyridinium bromide and 1-methyl-4-phenyl-pyridinium bromide are 0.67 and 0.3 mM, respectively. Inhibition of these enzymes may lead to impairment of cellular defense mechanisms.


FEBS Letters | 1987

Photooxidation products of primaquine: structure, antimalarial activity and hemolytic effects

Arnold Brossi; Wieslaw Gessner; Charles D. Hufford; John K. Baker; Frederic Homo; Pascal Millet; I. Landau

Photooxidation of primaquine (1) and 5‐hydroxyprimaquine (5) afforded a blue dye for which o‐quinone structure 4 was elaborated. Similar oxidation of N‐ethoxyacetylprimaquine (10) afforded o‐quinone 11. Tissue schizontocidal activity of 4 and 11, and bisquinolylmethine 3 prepared earlier, showed that none of them had noteworthy antimalarial activity, but all three produced methemoglobin.


FEBS Letters | 1986

Studies on the mechanism of MPTP oxidation by human liver monoamine oxidase B

Wieslaw Gessner; Arnold Brossi; Michael E. Bembenek; Richard R. Fritz; Creed W. Abell

The neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) and its deuterated analogues were oxidized to their corresponding dihydropyridinium species (MPDP+) by preparations of pure human liver MAO B : monoclonal antibody complex to investigate the mechanism of MPTP activation. Lineweaver‐Burk plots of initial reaction rates revealed that the K m,app values for the various deuterated MPTP analogues were similar to those of MPTP. In contrast, V max,app values were substantially decreased by substitution of deuterium for hydrogen on the tetrahydropyridinium ring, especially at C‐6. Deuterium substitution on the N‐methyl group alone did not significantly reduce V max,app. These studies support the interpretation that oxidation of MPTP at the C‐6 position on the tetrahydropyridine ring is a major rate‐determining step in its biotransformation by MAO B.


Synthetic Communications | 1985

Reduction of Phenyl-Substituted Pyridinium Methoiodides with Sodium Borohydride. Formation of Amine-Borane Complexes in Water

Wieslaw Gessner; Arnold Brossi

Abstract Reduction of phenyl-substituted pyridinium methoiodides with sodium borohydride in water afforded besides the desired tetrahydropyridines substantial amounts of amine-borane complexes. Reduction in methanol afforded tetrahydropyridines in high yield, with almost no amine-boranes formed.


Synthetic Communications | 1988

Improved Synthesis of the Lukes-ŜOrm Dilactam. Nucleophilic Opening to 5-Substituted 2-Pyrrolidine-2-Ones

Ricardo Alonso; Wieslaw Gessner; Kimio Takahashi; Arnold Brossi

Abstract An improved synthesis of the Lukes-Ŝorm dilactam 3 and conversion into several 5-substituted pyrrolidine-2-ones are described.


Synthetic Communications | 1988

C(9)-Butylated Lactams Related to Perhydrohistrionicotoxin

Wieslaw Gessner; Arnold Brossi; Judith L. Flippen-Anderson; Clifford George

Abstract The unsubstituted ketospirolactam 1 afforded on alkyla-tion the two C(9)-butylated ketolactams 2 and 3, with 3 being the more stabile epimer, and the C(9)-dibutylated ketolactam 4. Structure of alcohol 5 obtained from 3 was secured by X-ray analysis.


Journal of Medicinal Chemistry | 1990

Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines.

Michael E. Bembenek; Creed W. Abell; Linda A. Chrisey; Maria D. Rozwadowska; Wieslaw Gessner; Arnold Brossi


Journal of Medicinal Chemistry | 1985

Synthesis and dihydropteridine reductase inhibitory effects of potential metabolites of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Wieslaw Gessner; Arnold Brossi; Rong sen Shen; Creed W. Abell

Collaboration


Dive into the Wieslaw Gessner's collaboration.

Top Co-Authors

Avatar

Arnold Brossi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Creed W. Abell

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Michael E. Bembenek

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Richard R. Fritz

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Kimio Takahashi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Rong-Sen Shen

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bernhard Witkop

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Clifford George

United States Naval Research Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge